Mary E. Strek

11.8k total citations · 1 hit paper
124 papers, 5.5k citations indexed

About

Mary E. Strek is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Mary E. Strek has authored 124 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Pulmonary and Respiratory Medicine, 44 papers in Physiology and 29 papers in Epidemiology. Recurrent topics in Mary E. Strek's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (94 papers), Sarcoidosis and Beryllium Toxicity Research (27 papers) and Medical Imaging and Pathology Studies (27 papers). Mary E. Strek is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (94 papers), Sarcoidosis and Beryllium Toxicity Research (27 papers) and Medical Imaging and Pathology Studies (27 papers). Mary E. Strek collaborates with scholars based in United States, United Kingdom and France. Mary E. Strek's co-authors include Imre Noth, Rekha Vij, Karen Patterson, Ayodeji Adegunsoye, Justin M. Oldham, Alan R. Leff, Leah J. Witt, Edward T. Naureckas, Toby M. Maher and Pamela J. McShane and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Mary E. Strek

112 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

2015 655 citations David A. Lynch, Imre Noth et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary E. Strek United States	40	4.4k	1.9k	1.3k	1.0k	777	124	5.5k
Imre Noth United States	41	5.3k 1.2×	2.0k 1.0×	937 0.7×	909 0.9×	757 1.0×	143	6.1k
Yutaro Nakamura Japan	40	3.3k 0.7×	1.4k 0.7×	1.4k 1.0×	528 0.5×	787 1.0×	206	5.0k
Sonoko Nagai Japan	38	4.3k 1.0×	2.0k 1.1×	1.4k 1.1×	527 0.5×	787 1.0×	117	5.8k
Tomoyuki Fujisawa Japan	37	3.1k 0.7×	1.3k 0.7×	1.4k 1.0×	476 0.5×	735 0.9×	222	4.7k
Jeffrey J. Swigris United States	39	6.6k 1.5×	2.5k 1.3×	1.5k 1.2×	1.1k 1.1×	1.2k 1.5×	103	7.7k
Jin Woo Song South Korea	35	3.8k 0.9×	1.5k 0.8×	963 0.7×	437 0.4×	441 0.6×	193	4.5k
Francesco Bonella Germany	41	3.9k 0.9×	1.3k 0.7×	576 0.4×	360 0.4×	422 0.5×	212	4.5k
Wim Wuyts Belgium	39	4.1k 0.9×	1.6k 0.9×	642 0.5×	493 0.5×	412 0.5×	199	5.3k
Elizabeth A. Fagan United Kingdom	21	3.1k 0.7×	1.0k 0.6×	1.1k 0.8×	260 0.3×	433 0.6×	51	4.3k
Dominique Israël‐Biet France	32	2.3k 0.5×	761 0.4×	999 0.8×	326 0.3×	257 0.3×	151	4.3k

Countries citing papers authored by Mary E. Strek

Since Specialization

Citations

This map shows the geographic impact of Mary E. Strek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Strek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Strek more than expected).

Fields of papers citing papers by Mary E. Strek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Strek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Strek. The network helps show where Mary E. Strek may publish in the future.

Co-authorship network of co-authors of Mary E. Strek

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Strek. A scholar is included among the top collaborators of Mary E. Strek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Strek. Mary E. Strek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alqalyoobi, Shehabaldin, Jennifer A. Smith, Manoj V. Maddali, et al.. (2025). Proteomic Biomarkers of Survival in Non–Idiopathic Pulmonary Fibrosis Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 211(8). 1452–1462.

Wang, Jennifer M., Ayodeji Adegunsoye, Janelle Vu Pugashetti, et al.. (2025). A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 211(10). 1785–1793. 1 indexed citations

Studnicka, Michael, Jakub Gregor, Petra Ovesná, et al.. (2025). Hospitalisations in patients with idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry and EMPIRE Registry. ERJ Open Research. 12(1). 402–2025.

Upadhyay, Vaibhav, Sara E. Vazquez, Cathryn T. Lee, et al.. (2024). Phage Immunoprecipitation‐Sequencing Reveals CDHR5 Autoantibodies in Select Patients With Interstitial Lung Disease. ACR Open Rheumatology. 6(9). 568–580. 2 indexed citations

Maleckar, Spring, et al.. (2024). Improvement in Pulmonary Function in a Patient With ILD Following Semaglutide Therapy. A2047–A2047.

Pugashetti, Janelle Vu, J. Kim, Swaraj Bose, et al.. (2024). Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis. A1006–A1006.

Humphries, Stephen M., David Baraghoshi, Matthew Strand, et al.. (2024). Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes. American Journal of Respiratory and Critical Care Medicine. 209(9). 1121–1131. 18 indexed citations

Pugashetti, Janelle Vu, John S. Kim, Swaraj Bose, et al.. (2024). Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis. American Journal of Respiratory and Critical Care Medicine. 210(5). 639–647. 4 indexed citations

Huang, Yong, Shwu‐Fan Ma, Justin M. Oldham, et al.. (2024). Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 210(4). 444–454. 12 indexed citations

10.

Lee, Cathryn T., et al.. (2024). The impact of antifibrotic use on long-term clinical outcomes in the pulmonary fibrosis foundation registry. Respiratory Research. 25(1). 255–255. 3 indexed citations

11.

Chelala, Lydia, Luis Landeras, Huihua Li, et al.. (2023). Pulmonary Alveolar Proteinosis–associated Pulmonary Fibrosis: Evolutional Changes and Radiologic-Pathologic Correlation. Radiology Cardiothoracic Imaging. 5(5). e230040–e230040. 3 indexed citations

12.

Kim, John S., Shwu‐Fan Ma, Z. Jennie, et al.. (2023). Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis. CHEST Journal. 165(3). 621–631. 8 indexed citations

13.

Huang, Yong, Justin M. Oldham, Shwu‐Fan Ma, et al.. (2021). Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells. American Journal of Respiratory and Critical Care Medicine. 204(2). 197–208. 28 indexed citations

14.

Liu, Gabrielle Y., Iazsmin Bauer Ventura, Brett M. Elicker, et al.. (2019). Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis. CHEST Journal. 156(4). 715–723. 44 indexed citations

15.

Maher, Toby M. & Mary E. Strek. (2019). Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat. Respiratory Research. 20(1). 205–205. 169 indexed citations

16.

Richeldi, Luca, Francesco Varone, Miguel Bergna, et al.. (2018). Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence. European Respiratory Review. 27(150). 180074–180074. 67 indexed citations

17.

Adegunsoye, Ayodeji, Justin M. Oldham, Catherine A. Bonham, et al.. (2018). Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation. American Journal of Respiratory and Critical Care Medicine. 199(6). 747–759. 27 indexed citations

18.

Oldham, Justin M., Shwu‐Fan Ma, Fernando J. Martínez, et al.. (2015). TOLLIP , MUC5B , and the Response to N -Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 192(12). 1475–1482. 218 indexed citations

19.

McShane, Pamela J., Edward T. Naureckas, Gregory Tino, & Mary E. Strek. (2013). Non–Cystic Fibrosis Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 188(6). 647–656. 251 indexed citations

20.

McShane, Pamela J., Edward T. Naureckas, & Mary E. Strek. (2012). Bronchiectasis in a Diverse US Population. CHEST Journal. 142(1). 159–167. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact